Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As far as I can recall, RNVA has never delayed the release of their fins this long, which makes me believe something good awaits all of us. This is a good time to be an investor of RNVA.
I honestly believe so.
Good luck to us all.
I had never been as confidence with this ticker than now. Very soon the fireworks will begin to sound off!
RNVA, let's go!!!!!
I don't know why knuckleheads act like they know what they don't know, they don't know.
Hmmmm! But, they are still here!?
I wonder why?
Hey toohot, happy to see you around!
We'll have our day.
I believe that BIEL will rise one day!
Not a quitter...100% BIEL Strong!
Let's go RNVA!!!!!
Wow! Wow! It appears everyone has gravitated towards RNVA, and not FOXO. Hmmmm...something is about to pop!!
Let's go RNVA!!!!
2024, that is it!
I honestly believe RNVA investors will be paid bigly!
JMHO
All I can say is "You" are here for a purpose. I hope you find or get what you are here for.
You seem to be tired. Get some rest and hope tomorrow is D day!
Ciao!!!
I am seeing some not too familiar names here. That's a sign that something is about to go down based on my experience.
Happy to see you!
Take note newbies. I am ready for the unexpected.
Good luck!
Remember that he who laughs last laughs the best.
RNVA investors will have the last laugh.
I remain very hopeful. Good luck to us all!
We may, I repeat "May" begin to leave trip zeros in a couple of weeks. JMHO
Best of luck to us all!!!
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.
June 14 2024 - 8:30AM
Alert
Print
Share On Facebook
FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced it has entered into two share exchange agreements with Rennova Health, Inc., an OTC listed company (“Rennova”) (OTC: RNVA). In the first agreement, equity in Myrtle Recovery Centers, Inc., Rennova’s behavioral health services subsidiary, will be exchanged for $500,000 of common stock in FOXO, subject to adjustments. In the second agreement, equity in Rennova Community Health, Inc., which owns and manages Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access hospital, will be exchanged for $20 million of convertible preferred stock to be designated. Closing of the transactions are subject to certain closing conditions including but not limited to shareholder approval for the acquisition of Rennova Community Health, Inc. Scott County Community Hospital, Inc. and Myrtle Recovery Centers, Inc., generated unaudited net revenue of approximately $18.7 million and net income of approximately $5.2 million for the twelve months ended December 31, 2023.
Myrtle Recovery Centers, Inc. is a 30-bed behavioral health facility in East Tennessee with plans to duplicate the model in different locations. It provides inpatient services for detox and residential treatment and outpatient services for medication medication-assisted treatment (MAT) and office-based opioid treatment (OBOT) programs. Scott County Community Hospital, Inc. (DBA Big South Fork Medical) is a designated critical access hospital (CAH) in East Tennessee. The integration of these entities is designed to accelerate the growth of both companies while enabling FOXO Technologies to leverage its cutting-edge epigenetic technology in community health and addiction recovery settings, driving improved patient outcomes and expanding its market reach.
Mark White, Interim CEO of FOXO Technologies, “This acquisition represents a transformative step for FOXO Technologies. Myrtle Recovery Centers and Scott County Community Hospital are established businesses with opportunities for continued growth. Moreover, these transactions bring meaningful cash flow to FOXO. Our plan is to considerably grow these revenues over the next couple of years, including from the rights we secured to expand these businesses into another East Tennessee property owned by Rennova. Furthermore, Rennova’s history in diagnostic testing, coupled with its expertise in healthcare IT and software, creates additional opportunities for FOXO to expand and deliver our current technologies to the marketplace. We believe these transactions represent a key inflection point for FOXO by combining our innovative epigenetic and AI-based epigenetic solutions, such as the VITHAR™ AI Health Coach, with their robust healthcare services to bring an unprecedented level of care to patients. We look forward to providing further updates as we advance these important transactions."
“We are delighted to enter into these transactions with FOXO,” said Seamus Lagan, the Chief Executive Officer of Rennova Health Inc. “The two agreements have the potential to drive significant value and synergies for both our respective companies. In particular, we believe this transaction will enable us to rapidly expand our core business. In addition, by combining our established healthcare operations with FOXO’s expertise in AI and epigenetics, we foresee a powerful synergy that will enhance our service offerings and broaden our impact in the healthcare sector. This partnership is not only a strategic alignment for growth but also a major step forward in our mission to provide top-tier healthcare services and improve patient outcomes.”
Additional details about the transactions are available in the Company’s Form 8-K, which has been filed with the Securities and Exchange Commission.
About Rennova Health, Inc.
Rennova Health, Inc. (“Rennova,”) is a provider of health care services. The company owns one operating hospital in Oneida, Tennessee known as Big South Fork Medical Center, a hospital located in Jamestown, Tennessee that it plans to reopen, and an alcohol and drug treatment facility and OBOT operated by Myrtle Recovery Centers, Inc. For more information, please visit www.rennovahealth.com.
About FOXO Technologies Inc.
FOXO is a biotechnology company dedicated to improving human health and longevity through the development of cutting-edge technology and product solutions for various industries, including life insurance. FOXO’s epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. FOXO is committed to leveraging the latest advancements in science and technology to help people live better, longer lives. For more information about FOXO, visit www.foxotechnologies.com.
Forward-Looking Statements
This press release contains certain forward-looking statements for purposes of the “safe harbor” provisions under the United States Private Securities Litigation Reform Act of 1995. Any statements other than statements of historical fact contained herein, including statements about the delisting of the Warrants from NYSE American, trading of the Warrants in the over-the-counter market, the continued listing of the Company’s Class A common stock on NYSE American, and other statements identified by words such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “believe,” “intend,” “plan,” “projection,” “outlook” or words of similar meaning, but the absence of these words does not mean that a statement is not forward-looking. Any such forward-looking statements are based upon the current beliefs and expectations of the Company’s management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond the Company’s control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the possibility that the Plan will not be accepted by NYSE American, the Company will be unable to satisfy other continued listing requirements of NYSE American for its Class A common stock to maintain the listing of the Class A common stock on NYSE American; the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates, including the highly regulated insurance industry. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact:
Crescendo Communications, LLC
(212) 671-1020
foxo@crescendo-ir.com
I believe CEO Seamus is ready to reward his investors graciously for the pain and suffering.
Good luck to All!!!
Buzzy, you killed this one!
This is done, done!
All aboard ...RNVA is getting ready for take off!
I'm think RNVA. wants to reward all of its investors. Otherwise, it would traded above 0.0002 to off load some investors and reload before taking off. Good luck to all!
When might that be?
Feels more like it.
Good luck and best wishes to all!
I have never felt soo good about RNVA.
Great things abound!
The Rise of SHIB: A Crypto Odyssey
Explore the Shiba Inu saga—the mesmerizing and inspiring story of the samurai pup that took the world by storm, making its mark in history as the meme that became a cultural phenomenon.
What comes down can go up...the law of reverse returns.🤣
I smell .50 in 2 weeks. JMHO
I believe we will win!
What Is the OTC Markets Expert Market? Securities Lawyer Blog
Most of the companies quoted on OTC Markets are not able to meet the minimum listing requirements for trading on a national securities exchange. Many of these companies do not file periodic reports or audited financial statements with the SEC, making it difficult for the public to find current, reliable information about those companies. Companies quoted on the OTC Markets are divided into four tiers, the OTCQX, the OTCQB, the OTC Pink and the Expert Market. Companies on the Expert Market provide the lowest level of disclosure in comparison to other OTC Market tiers. As a result, trading is limited to quotation on an unsolicited basis.
On October 15, OTC Markets reported that “2,247 former Pink No Information securities shifted to the Expert Market tier, where securities may only be quoted on an Unsolicited (customer order) basis. Quotes of securities in the Expert Market are “Unsolicited Only,” which means that trades of securities subject to unsolicited quotation in the Expert Market are only available to broker-dealers, institutions and other sophisticated investors, and not average investors.
The SEC’s amendments to Rule 15c2-11 became effective on September 28, 2021. Amended Rule 15c2-11 eliminated broker-dealer quotes of securities of issuers that fail to make current information publicly available. With the amendments to Rule 15c2-11, the OTC Markets Group Expert Market became the platform for broker-dealers to publish unsolicited quotes of securities designated as “No Information” securities. Typically, these are companies not subject to or not in compliance with SEC public company reporting requirements.
Because of the restrictions imposed on securities quoted on the Expert Market, most investors will not be able to publicly sell their shares. Additionally, they will not have access to bid and ask prices or other information, including trading volume. As such, Expert Market shares are illiquid.
Companies moved to the Expert Market from another OTC Markets tier can apply to relist on the OTC Pink or other OTC Markets tier by becoming an SEC reporting company, submitting a new Form 211, and meeting OTC Markets requirements for the particular tier.
Hamilton & Associates Law Group can assist companies on the Expert Market with uplisting to other OTC Market tiers. For further information, please contact Brenda Hamilton, Securities Attorney, at 200 E. Palmetto Park Rd, Suite 103, Boca Raton, Florida, (561) 416-8956, by email info@securitieslawyer101.com or visit www.securitieslawyer101.com.
This securities law blog post is provided as a general informational service to clients and friends of Hamilton & Associates Law Group and should not be construed as and does not constitute legal advice on any specific matter, nor does this message create an attorney-client relationship. Please note that the prior results discussed herein do not guarantee similar outcomes.
Hamilton & Associates | Securities Lawyers
Brenda Hamilton, Securities Attorney
200 E. Palmetto Park, Suite 103
Boca Raton, Florida 33432
Full throttle this week starting on Tuesday. I'll trust the process while await the fins.
Good luck to all!
Awesome...blessings!
SEC approves Ethereum ETFs, aligning ETH closer to commodity in industry win
Ethereum's commodity classification gains ground with SEC's landmark ETF approval, boosting investor interest.
Liam 'Akiba' WrightMay. 23, 2024 at 10:09 pm UTC
The US Securities and Exchange Commission (SEC) has approved the first spot Ethereum exchange-traded funds (ETFs), marking a significant milestone for the crypto industry. The decision, announced today, allows asset managers such as Grayscale, Fidelity, and Bitwise to launch ETFs that directly track the price of Ethereum (ETH).
Ethereum rose 2% on the news and was trading at $3,900 as of press time, based on CryptoSlate data.
The approval follows a rigorous application process and extensive market analysis. Grayscale’s Chief Legal Officer, Craig Salm, previously highlighted that the SEC had already addressed key issues during the approval of spot Bitcoin ETFs, which are applicable to Ethereum ETFs as well. These issues include creation and redemption processes, cash versus in-kind transactions, and custody concerns. Salm emphasized that the SEC’s prior engagement with Bitcoin ETF issuers laid the groundwork for Ethereum ETFs, noting the strong correlation between ETH futures and spot prices as a compelling factor for approval.
The SEC’s decision comes after a period of uncertainty and skepticism among market analysts. Bloomberg analyst Eric Balchunas had previously estimated a 25% chance of approval by May 23, citing the SEC’s lack of engagement compared to the Bitcoin ETF approval process. However, the approval of spot Bitcoin ETFs earlier this year, Hong Kong’s ETH ETF approval, and recent crypto wins in Congress had raised hopes among crypto proponents despite the SEC’s historically cautious stance under Gary Gensler’s leadership.
The approval process included a public comment period, during which the SEC sought feedback on various aspects of the proposed ETFs, including custodianship of funds, creation, and redemption models, and sponsor fees. This phase mirrored the approach taken with spot Bitcoin ETF applications, encouraging feedback from US citizens and organizations.
The approval of spot Ethereum ETFs is expected to have a significant impact on the digital assets market. Hong Fang, president of crypto exchange OKX, noted that while Ethereum’s price has risen this year, it has lagged behind Bitcoin’s gains, a disparity likely influenced by market anticipation of the SEC’s decision. The approval is anticipated to boost investor confidence and increase market liquidity.
Several issuers filed applications to list their ETF on the NYSE Arca exchange, with Coinbase Custody serving as the custodian. Bitwise’s analysis demonstrated a strong correlation between the ETH spot market and the CME ETH futures market, a critical factor in meeting SEC requirements to monitor potential market manipulation.
Despite the positive outcome, some industry insiders had expressed concerns about the SEC’s approach. Participants in recent meetings with the SEC described the talks as one-sided, with agency staff withholding substantive comments on the proposals. This contrasted with the detailed discussions that preceded the SEC’s approval of spot Bitcoin ETFs.
The approval also comes amid ongoing regulatory scrutiny of Ethereum’s classification as either a security or a commodity. Reports suggest that the SEC is investigating Ethereum’s regulatory classification, which added uncertainty to the approval prospects. However, today’s decision indicates a favorable stance towards Ethereum-based financial products and a potential indication that Ethereum can be considered a commodity.
The approval is a landmark event for the crypto industry, reflecting the growing interest in crypto-asset financial products among traditional investment firms. As the market reacts to this development, stakeholders will closely monitor the performance and impact of these newly approved ETFs.
Ethereum Market Data
At the time of press 10:20 pm UTC on May. 23, 2024, Ethereum is ranked #2 by market cap and the price is up 2.97% over the past 24 hours. Ethereum has a market capitalization of $461.12 billion with a 24-hour trading volume of $41.29 billion. Learn more about Ethereum ›
Crypto Market Summary
At the time of press 10:20 pm UTC on May. 23, 2024, the total crypto market is valued at at $2.53 trillion with a 24-hour volume of $132.2 billion. Bitcoin dominance is currently at 52.57%. Learn more about the crypto market ›
Mentioned in this article
Editor Editor
Assad Jafri
Editor & Reporter at CryptoSlate
AJ, a passionate journalist since Yemen's 2011 Arab Spring, has honed his skills worldwide for over a decade. Specializing in financial journalism, he now focuses on crypto reporting.
Latest Alpha Market Report
I'm trusting the process.
BIEL train might be slowed down but can't be stopped.
While you stand aside and wait, accumulate.
While you stand aside and wait, accumulate.
I will trust the process while I sit aside and wait.
BIEL Train Is Rerouted, But Has Not Yet Stopped.
In It To Win It.
Patiently awaiting fins. Expecting the best.
Expecting a home run fins.
Lwt's go RNVA!!!!!
I decree and declare that the we get a nice run after the filings!
No News Means Good News...JMHO.
FOMO to kick in very soon!
That is it!
A complaint about what?